AceDoPC, a structured phospholipid to target the brain with docosahexaenoic acid

AceDoPCr (R) is a structured phospholipid or acetyl-LysoPC-DHA made to prevent docosahexaenoic acyl migrating from the sn-2 to sn-1 position of the phospholipid, however keeping the main physical-chemical properties of LysoPC-DHA. As previously shown for LysoPC-DHA, AceDoPCr (R) allows DHA crossing a re-constituted blood-brain barrier with higher efficiency than non-esterified DHA or PC-DHA. When injected to blood of rats, AceDoPCr (R) is processed within the brain to deliver DHA to phosphatidyl-choline and -ethanolamine. When injected to rats following the induction of an ischemic stroke, AceDoPCr (R) prevents the extension of brain lesions more efficiently than DHA. Overall, these properties make AceDoPCr (R) a promising phospholipid carrier of DHA to the brain.